<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04621734</url>
  </required_header>
  <id_info>
    <org_study_id>HSC20190225H</org_study_id>
    <nct_id>NCT04621734</nct_id>
  </id_info>
  <brief_title>Retention of Nasoenteric Feeding Tubes in Pediatric Patients Using a Nasal Bridle</brief_title>
  <official_title>Improving Retention of Nasoenteric Feeding Tubes in Pediatric Patients Using a Nasal Bridle</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The University of Texas Health Science Center at San Antonio</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The University of Texas Health Science Center at San Antonio</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A study to compare tube dislodgment rates when a nasoenteric feeding tube is secured with&#xD;
      adhesive tape vs the AMT BridlePro device.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The adhesive tape will be the tape available in the unit and will be placed by the nurse or&#xD;
      provider at the time of nasoenteric tube placement. The tape will be placed around the tube&#xD;
      and secured to the cheek on the side of tube. The tape will be replaced as needed per nursing&#xD;
      discretion when soiled or the adhesive properties are failing and this information will be&#xD;
      tracked. The AMT BridlePro will be placed by the nurse or provider at the time of nasoenteric&#xD;
      tube placement. Placement will use the BridlePro system included in the individual BridlePro&#xD;
      packaging. Placement and securement will follow manufacturer recommendations and teaching.&#xD;
      The BridlePro encircles the vomer bone of the nasal cavity to secure the tube. Sedation&#xD;
      medication may be given per standard of care for nasoenteric tube placement at the discretion&#xD;
      of the provider team but no separate or additional sedation medication will be given for&#xD;
      securement with adhesive tape or the BridlePro.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">February 18, 2020</start_date>
  <completion_date type="Anticipated">April 30, 2022</completion_date>
  <primary_completion_date type="Actual">April 30, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of tube dislodgments</measure>
    <time_frame>Period of hospitalization (no more than 30 days)</time_frame>
    <description>The number of times the tube is dislodged during hospitalization</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time to dislodgement</measure>
    <time_frame>Period of hospitalization (no more than 30 days)</time_frame>
    <description>Measurement of time until nasoenteric tube is dislodged and needs to be repositioned</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of radiographs for tube replacement</measure>
    <time_frame>Period of hospitalization (no more than 30 days)</time_frame>
    <description>Number of X-rays required to reposition tube.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cost of replacement tubes and follow up radiographs</measure>
    <time_frame>Period of hospitalization (no more than 30 days)</time_frame>
    <description>Extra costs involved in replacing tubes and performing radiographs</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time of missed nutrition</measure>
    <time_frame>Period of hospitalization (no more than 30 days)</time_frame>
    <description>Amount of time that nutrition was missed due to tube replacement</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">36</enrollment>
  <condition>Feeding Tube Complication</condition>
  <arm_group>
    <arm_group_label>Nasal bridle to secure feeding tube</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The nasal bridle will be used to secure the nasoenteric feeding tube.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Adhesive Tape use to secure feeding tube</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Adhesive tape will be used as standard of care to secure the nasoenteric feeding tube.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>AMT BridlePro Device</intervention_name>
    <description>A device used as an alternative securement method using the structure of the nasal cavity to secure the nasoenteric tube.</description>
    <arm_group_label>Nasal bridle to secure feeding tube</arm_group_label>
    <other_name>Applied Medical Technology (AMT) BridlePro Device</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Adhesive Tape</intervention_name>
    <description>Adhesive tape used to secure nasoenteric tube</description>
    <arm_group_label>Adhesive Tape use to secure feeding tube</arm_group_label>
    <other_name>Tape</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Need for nasoenteric feeding&#xD;
&#xD;
          -  Admitted to University Hospital&#xD;
&#xD;
          -  Age 0-18 years&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Facial trauma&#xD;
&#xD;
          -  Nasal airway obstructions&#xD;
&#xD;
          -  Thrombocytopenia (&lt;100 K/Î¼L)&#xD;
&#xD;
          -  s/p septoplasty&#xD;
&#xD;
          -  Patients with vomer bone graft&#xD;
&#xD;
          -  Nasoenteric feeding tube placed and secured prior to being screened for study&#xD;
&#xD;
          -  Contraindication for the use of the BridlePro&#xD;
&#xD;
          -  Does not meet inclusion criteria&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Veronica Armijo, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Texas Health at San Antonio</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Health System</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>78229</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>November 3, 2020</study_first_submitted>
  <study_first_submitted_qc>November 3, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">November 9, 2020</study_first_posted>
  <last_update_submitted>June 18, 2021</last_update_submitted>
  <last_update_submitted_qc>June 18, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 21, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>The University of Texas Health Science Center at San Antonio</investigator_affiliation>
    <investigator_full_name>Veronica Armijo-Garcia</investigator_full_name>
    <investigator_title>Associate Professor/Clinical, Pediatrics-Critical Care</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

